Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Am J Reprod Immunol ; 73(6): 545-56, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25648617

RESUMO

PROBLEM: We investigated the effect of Xianziyizhen recipe capsule (XRC), a kidney-tonifying herb, on the PGI2-PPARδ signaling pathway at the maternal-fetal interface in embryo implantation dysfunction (EID) mice. METHOD OF STUDY: Intragastric administration of Progynova (estradiol) or XRC was performed in EID mouse model, following experimental induction of kidney deficiency by co-treatment with chemotherapy drug hydroxyurea and antiprogesterone mifepristone. The PPARδ and IL-11 mRNA expression in endometrium were detected by real-time relative reverse transcription-polymerase chain reaction (RT-PCR). Further, the protein expression of COX-2, PGI2, MMP-9, and TIMP-3 was detected in endometrial glandular epithelium and in stromal cells by immunohistochemical (IHC) assay. RESULTS: The results showed that hydroxyurea and mifepristone-induced EID were associated with significantly lower PPARδ and IL-11 mRNA levels in endometrium and reduced COX-2, PGI2, MMP-9, and TIMP-3 levels in endometrial glandular epithelium, compared with normal controls. However, XRC and Progynova treatment reversed these effects, leading to significant increases in PPARδ and IL-11 mRNA expression, and COX-2, PGI2, MMP-9 and TIMP-3 protein levels, when compared with the levels observed in EID mice. CONCLUSION: These results strongly suggested that XRC is beneficial in EID treatment and that XRC may mediate its effects through regulation of the PGI2-PPARδ signaling pathway.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Implantação do Embrião/efeitos dos fármacos , Endométrio/imunologia , Epoprostenol/imunologia , Receptores Citoplasmáticos e Nucleares/imunologia , Animais , Ciclo-Oxigenase 2/biossíntese , Ciclo-Oxigenase 2/imunologia , Implantação do Embrião/imunologia , Endométrio/citologia , Células Epiteliais/citologia , Células Epiteliais/imunologia , Epoprostenol/biossíntese , Feminino , Interleucina-11/biossíntese , Interleucina-11/imunologia , Metaloproteinase 9 da Matriz/biossíntese , Metaloproteinase 9 da Matriz/imunologia , Camundongos , Gravidez , Receptores Citoplasmáticos e Nucleares/metabolismo , Células Estromais/citologia , Células Estromais/imunologia , Inibidor Tecidual de Metaloproteinase-3/biossíntese , Inibidor Tecidual de Metaloproteinase-3/imunologia
2.
Zhongguo Zhong Yao Za Zhi ; 37(21): 3236-9, 2012 Nov.
Artigo em Chinês | MEDLINE | ID: mdl-23397720

RESUMO

OBJECTIVE: To optimize the process for preparing genipin with enzymolyzed geniposide by an orthogonal experiment. METHOD: The optimal enzymolysis process was selected by an orthogonal experiment, with the concentration of geniposide as the index as well as enzyme quantity, pH of enzymolysis solution, enzymolysis time and enzymolysis temperature as considerations. RESULT: The optimal hydrolysis conditions were as follow: rough genipin samples at the concentration of 40 g x L(-1) were selected and shook on a table concentrator at a speed of 100 r x min(-1), added with beta-glucosidase-geniposide 1 : 1 (weight proportion), with pH of enzymolysis solution at 4.5, hydrolyzation temperature at 50 degrees C, the conversion rate of genipin could reach 85.8%. CONCLUSION: The process is so stable and feasible that it can provide theoretical basis for the preparation of genipin with enzymolyzed geniposide.


Assuntos
Iridoides/química , Hidrólise , Tecnologia Farmacêutica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA